CN102631493B - 一种保健组合物 - Google Patents
一种保健组合物 Download PDFInfo
- Publication number
- CN102631493B CN102631493B CN2012101220086A CN201210122008A CN102631493B CN 102631493 B CN102631493 B CN 102631493B CN 2012101220086 A CN2012101220086 A CN 2012101220086A CN 201210122008 A CN201210122008 A CN 201210122008A CN 102631493 B CN102631493 B CN 102631493B
- Authority
- CN
- China
- Prior art keywords
- cordyceps
- parts
- ginseng
- composition
- saffron
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 35
- 230000036541 health Effects 0.000 title claims abstract description 16
- 241000190633 Cordyceps Species 0.000 claims abstract description 77
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 35
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 33
- 235000008434 ginseng Nutrition 0.000 claims abstract description 33
- 240000002900 Arthrospira platensis Species 0.000 claims abstract description 28
- 235000016425 Arthrospira platensis Nutrition 0.000 claims abstract description 28
- 244000124209 Crocus sativus Species 0.000 claims abstract description 28
- 235000015655 Crocus sativus Nutrition 0.000 claims abstract description 28
- 235000013974 saffron Nutrition 0.000 claims abstract description 28
- 239000004248 saffron Substances 0.000 claims abstract description 28
- 229940082787 spirulina Drugs 0.000 claims abstract description 28
- 210000001320 hippocampus Anatomy 0.000 claims abstract description 25
- 241000893536 Epimedium Species 0.000 claims abstract description 22
- 235000018905 epimedium Nutrition 0.000 claims abstract description 21
- 201000001881 impotence Diseases 0.000 claims abstract description 21
- 230000036039 immunity Effects 0.000 claims abstract description 11
- 230000002929 anti-fatigue Effects 0.000 claims abstract description 9
- 241000208340 Araliaceae Species 0.000 claims description 34
- 239000003814 drug Substances 0.000 claims description 24
- 238000002360 preparation method Methods 0.000 claims description 19
- TZJALUIVHRYQQB-XFDQAQKOSA-N Icariin Natural products O(C)c1ccc(C2=C(O[C@H]3[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)C(=O)c3c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O4)c(C/C=C(\C)/C)c3O2)cc1 TZJALUIVHRYQQB-XFDQAQKOSA-N 0.000 claims description 13
- TZJALUIVHRYQQB-XLRXWWTNSA-N icariin Chemical compound C1=CC(OC)=CC=C1C1=C(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)C(=O)C2=C(O)C=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-XLRXWWTNSA-N 0.000 claims description 13
- TZJALUIVHRYQQB-UHFFFAOYSA-N icariine Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(C)O2)O)C(=O)C2=C(O)C=C(OC3C(C(O)C(O)C(CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-UHFFFAOYSA-N 0.000 claims description 13
- 229940079593 drug Drugs 0.000 claims description 8
- 239000006186 oral dosage form Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 27
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 20
- 238000000034 method Methods 0.000 description 19
- 238000012360 testing method Methods 0.000 description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 239000000284 extract Substances 0.000 description 14
- 239000002775 capsule Substances 0.000 description 13
- 230000006870 function Effects 0.000 description 13
- 210000003734 kidney Anatomy 0.000 description 12
- 239000000843 powder Substances 0.000 description 12
- 241000699666 Mus <mouse, genus> Species 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 230000037396 body weight Effects 0.000 description 10
- 210000000952 spleen Anatomy 0.000 description 10
- 238000005728 strengthening Methods 0.000 description 10
- 239000002904 solvent Substances 0.000 description 9
- 230000036737 immune function Effects 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 230000002708 enhancing effect Effects 0.000 description 6
- 206010016256 fatigue Diseases 0.000 description 6
- 239000000546 pharmaceutical excipient Substances 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 5
- 206010057249 Phagocytosis Diseases 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 239000012141 concentrate Substances 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 210000005036 nerve Anatomy 0.000 description 5
- 230000008782 phagocytosis Effects 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 230000001568 sexual effect Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 230000009182 swimming Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 239000003937 drug carrier Substances 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 210000004698 lymphocyte Anatomy 0.000 description 4
- 210000000822 natural killer cell Anatomy 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 210000000628 antibody-producing cell Anatomy 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 239000003228 hemolysin Substances 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000004089 microcirculation Effects 0.000 description 3
- 210000003899 penis Anatomy 0.000 description 3
- 210000003024 peritoneal macrophage Anatomy 0.000 description 3
- 210000001541 thymus gland Anatomy 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 241001264174 Cordyceps militaris Species 0.000 description 2
- 241000192700 Cyanobacteria Species 0.000 description 2
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 240000005373 Panax quinquefolius Species 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000012752 auxiliary agent Substances 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000003405 delayed action preparation Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 239000012729 immediate-release (IR) formulation Substances 0.000 description 2
- 238000009863 impact test Methods 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- IYCPMVXIUPYNHI-WPKKLUCLSA-N 3,5-dihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one Chemical compound C1=CC(OC)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(CC=C(C)C)=C2O1 IYCPMVXIUPYNHI-WPKKLUCLSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000224489 Amoeba Species 0.000 description 1
- 241000620196 Arthrospira maxima Species 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 241001559542 Hippocampus hippocampus Species 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010058359 Hypogonadism Diseases 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001113425 Iridaceae Species 0.000 description 1
- 208000007466 Male Infertility Diseases 0.000 description 1
- 206010057672 Male sexual dysfunction Diseases 0.000 description 1
- 241000258241 Mantis Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241001597510 Mollia Species 0.000 description 1
- 240000001307 Myosotis scorpioides Species 0.000 description 1
- 241000238633 Odonata Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000813872 Oscillatoriaceae Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 235000002791 Panax Nutrition 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 241000688197 Pilosa Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- 208000032038 Premature aging Diseases 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 206010052005 Psychogenic erectile dysfunction Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000700608 Sagitta Species 0.000 description 1
- 241000130993 Scarabaeus <genus> Species 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 241001494489 Thielavia Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 210000002534 adenoid Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000000141 anti-hypoxic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000001599 crocus sativus l. flower extract Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000010515 dystocia Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 238000013123 lung function test Methods 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000008897 memory decline Effects 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 208000017983 photosensitivity disease Diseases 0.000 description 1
- 231100000434 photosensitization Toxicity 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 229940076591 saffron extract Drugs 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000035946 sexual desire Effects 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 235000003724 spirulina extract Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 238000009475 tablet pressing Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
组合物 | 例数 | 明显改善 | 改善 | 无效 | 总改善率% |
实施例1 | 114 | 87 | 14 | 13 | 88.6 |
实施例2 | 98 | 78 | 11 | 9 | 90.8 |
实施例3 | 103 | 82 | 10 | 11 | 89.3 |
实施例4 | 106 | 86 | 8 | 12 | 88.7 |
实施例5 | 99 | 81 | 10 | 8 | 91.9 |
对照组(虫草单剂胶囊) | 45 | 25 | 6 | 14 | 68.9 |
对照组(海马+人参胶囊) | 64 | 19 | 28 | 17 | 73.4 |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012101220086A CN102631493B (zh) | 2012-04-24 | 2012-04-24 | 一种保健组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012101220086A CN102631493B (zh) | 2012-04-24 | 2012-04-24 | 一种保健组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102631493A CN102631493A (zh) | 2012-08-15 |
CN102631493B true CN102631493B (zh) | 2013-08-28 |
Family
ID=46616173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012101220086A Active CN102631493B (zh) | 2012-04-24 | 2012-04-24 | 一种保健组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102631493B (zh) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1456204A (zh) * | 2003-01-03 | 2003-11-19 | 江西南昌桑海制药厂 | 一种益气补肾口服液 |
CN101862355A (zh) * | 2010-07-07 | 2010-10-20 | 郭景龙 | 一种具有提高免疫力作用的药物组合物 |
-
2012
- 2012-04-24 CN CN2012101220086A patent/CN102631493B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN102631493A (zh) | 2012-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100473413C (zh) | 一种治疗老年期痴呆的中药制剂 | |
CN102763873A (zh) | 天麻营养饮料及其生产工艺 | |
CN102319367A (zh) | 一种治疗慢性咽喉炎及声带疾病的药物 | |
CN103933487A (zh) | 一种治疗抑郁症的复方中药 | |
CN1314422C (zh) | 一种补益气血、温阳健脾十味扶正的药物及其制备方法 | |
CN102688471A (zh) | 一种具有抗疲劳作用的复方制剂 | |
CN102631492B (zh) | 提高免疫力、抗疲劳的中药组合物 | |
CN107158299B (zh) | 一种具有增强学习记忆力功能的组合物及其制备方法 | |
CN102784230B (zh) | 一种治疗营养性贫血的药物组合物制剂 | |
CN102631486B (zh) | 一种保健组合物 | |
CN102631506B (zh) | 提高免疫力、抗疲劳的中药组合物 | |
CN102631487B (zh) | 提高免疫力、抗疲劳的中药组合物 | |
CN101317900B (zh) | 一种防治酒精性肝损伤的中药组合物及制备方法 | |
CN102631490B (zh) | 提高免疫力、抗疲劳的中药组合物 | |
CN102631493B (zh) | 一种保健组合物 | |
CN102631393B (zh) | 一种保健组合物 | |
CN102274428B (zh) | 一种具有治疗肠易激综合症作用的药物组合物及其制备方法和应用 | |
CN102631498B (zh) | 中药组合物 | |
CN102631488B (zh) | 一种提高免疫力、抗疲劳的中药组合物 | |
CN102641339B (zh) | 一种提高机体免疫力、抗疲劳度的中药复方制剂 | |
CN102631496B (zh) | 提高免疫力、抗疲劳的中药组合物 | |
CN101411493A (zh) | 一种防治疲劳型亚健康的凉茶及其制备方法 | |
CN110559354A (zh) | 一种复方红景天组合物及其制备方法 | |
CN103598588B (zh) | 一种具有改善睡眠作用的保健食品 | |
CN105168519B (zh) | 具有改善睡眠功能的组合物及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220916 Address after: 224100 6, Jinfeng South Street, Dafeng District, Yancheng City, Jiangsu. Patentee after: Dafeng District Productivity Promotion Center, Yancheng City Address before: Ji Hongjinzhuan, Development Department, Jiangsu Huifeng Agrochemical Co., Ltd., South Head of Wanggang Zha, Dafeng City, Yancheng City, Jiangsu Province, 224100 Patentee before: Yang Cuihong |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20120815 Assignee: JIANGSU HUIFENG BIO AGRICULTURE Co.,Ltd. Assignor: Dafeng District Productivity Promotion Center, Yancheng City Contract record no.: X2023980042603 Denomination of invention: A health composition Granted publication date: 20130828 License type: Common License Record date: 20230926 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20120815 Assignee: DAFENG HEGNO PHARMACEUTICALS Co.,Ltd. Assignor: Dafeng District Productivity Promotion Center, Yancheng City Contract record no.: X2023980045165 Denomination of invention: A health composition Granted publication date: 20130828 License type: Common License Record date: 20231102 Application publication date: 20120815 Assignee: YANCHENG DESANO PHARMACEUTICAL Co.,Ltd. Assignor: Dafeng District Productivity Promotion Center, Yancheng City Contract record no.: X2023980045163 Denomination of invention: A health composition Granted publication date: 20130828 License type: Common License Record date: 20231102 Application publication date: 20120815 Assignee: JIANGSU BROTHER VITAMINS Co.,Ltd. Assignor: Dafeng District Productivity Promotion Center, Yancheng City Contract record no.: X2023980045158 Denomination of invention: A health composition Granted publication date: 20130828 License type: Common License Record date: 20231102 Application publication date: 20120815 Assignee: JIANGSU CHIA TAI FENGHAI PHARMACEUTICAL Co.,Ltd. Assignor: Dafeng District Productivity Promotion Center, Yancheng City Contract record no.: X2023980045154 Denomination of invention: A health composition Granted publication date: 20130828 License type: Common License Record date: 20231102 |
|
EC01 | Cancellation of recordation of patent licensing contract | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: JIANGSU CHIA TAI FENGHAI PHARMACEUTICAL Co.,Ltd. Assignor: Dafeng District Productivity Promotion Center, Yancheng City Contract record no.: X2023980045154 Date of cancellation: 20240703 |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20120815 Assignee: JIANGSU CHIA TAI FENGHAI PHARMACEUTICAL Co.,Ltd. Assignor: Dafeng District Productivity Promotion Center, Yancheng City Contract record no.: X2024980012768 Denomination of invention: A health care composition Granted publication date: 20130828 License type: Common License Record date: 20240822 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EC01 | Cancellation of recordation of patent licensing contract | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: DAFENG HEGNO PHARMACEUTICALS Co.,Ltd. Assignor: Dafeng District Productivity Promotion Center, Yancheng City Contract record no.: X2023980045165 Date of cancellation: 20240930 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20120815 Assignee: DAFENG HEGNO PHARMACEUTICALS Co.,Ltd. Assignor: Dafeng District Productivity Promotion Center, Yancheng City Contract record no.: X2024980019734 Denomination of invention: A health care composition Granted publication date: 20130828 License type: Common License Record date: 20241022 |
|
EC01 | Cancellation of recordation of patent licensing contract | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: YANCHENG DESANO PHARMACEUTICAL Co.,Ltd. Assignor: Dafeng District Productivity Promotion Center, Yancheng City Contract record no.: X2023980045163 Date of cancellation: 20241028 Assignee: JIANGSU HUIFENG BIO AGRICULTURE Co.,Ltd. Assignor: Dafeng District Productivity Promotion Center, Yancheng City Contract record no.: X2023980042603 Date of cancellation: 20241028 |
|
EC01 | Cancellation of recordation of patent licensing contract | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: JIANGSU BROTHER VITAMINS Co.,Ltd. Assignor: Dafeng District Productivity Promotion Center, Yancheng City Contract record no.: X2023980045158 Date of cancellation: 20241101 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20120815 Assignee: YANCHENG DESANO PHARMACEUTICAL Co.,Ltd. Assignor: Dafeng District Productivity Promotion Center, Yancheng City Contract record no.: X2024980021788 Denomination of invention: A health care composition Granted publication date: 20130828 License type: Common License Record date: 20241101 Application publication date: 20120815 Assignee: JIANGSU HUIFENG BIO AGRICULTURE Co.,Ltd. Assignor: Dafeng District Productivity Promotion Center, Yancheng City Contract record no.: X2024980021618 Denomination of invention: A health care composition Granted publication date: 20130828 License type: Common License Record date: 20241101 |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20120815 Assignee: JIANGSU BROTHER VITAMINS Co.,Ltd. Assignor: Dafeng District Productivity Promotion Center, Yancheng City Contract record no.: X2024980022496 Denomination of invention: A health care composition Granted publication date: 20130828 License type: Common License Record date: 20241105 |
|
EE01 | Entry into force of recordation of patent licensing contract |